GCTK logo

GlucoTrack (GCTK) Cash From Financing

Annual CFF

$8.73 M
+$8.73 M+100.00%

December 31, 2023

Summary

Performance

1-Year Change

+100%

3-Year Change

-32.89%

5-Year Change

+75.94%

15-Year Change

+51.81%

GCTK Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.95%
GCTK annual cash flow from financing activities is higher than 55.95% of companies in Healthcare sector

High & Low

All-time High

$13.01 M
GCTK annual cash flow from financing activities is currently -32.89% below its historical high of $13.01 million

3-Year Low

$0.00
GCTK annual cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GCTK previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
GCTK next annual earnings announcement is scheduled for May 15, 2025

OtherGCTKcash flowmetrics:

Annual CFI

$0.00
GCTK annual cash flow from investing activities is $0.00

Annual CFO

-$6.56 M
GCTK annual cash flow from operations is -$6.56 million

Annual FCF

-$6.56 M
GCTK annual free cash flow is -$6.56 million

Annual CAPEX

-
GCTK annual capital expenditures value is unknown

Quarterly CFF

$4.38 M
+$3.80 M+655.17%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+100%

3-Year Change

-

5-Year Change

+100%

GCTK Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.16%
GCTK quarterly cash flow from financing activities is higher than 79.16% of companies in Healthcare sector

High & Low

All-time High

$13.01 M
GCTK quarterly cash flow from financing activities is currently -66.33% below its historical high of $13.01 million

3-Year Low

$0.00
GCTK quarterly cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GCTK previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
GCTK next earnings announcement is scheduled for May 15, 2025

OtherGCTKcash flowmetrics:

Quarterly CFI

-$33.00 K
GCTK quarterly cash flow from investing activities is -$33.00 thousand

Quarterly CFO

-$4.14 M
GCTK quarterly cash flow from operations is -$4.14 million

Quarterly FCF

-$4.17 M
GCTK quarterly free cash flow is -$4.17 million

Quarterly CAPEX

-
GCTK quarterly capital expenditures value is unknown

TTM CFF

$4.96 M
+$4.38 M+755.17%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-43.18%

3-Year Change

-

5-Year Change

-61.87%

GCTK TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.81%
GCTK TTM cash flow from financing activities is higher than 42.81% of companies in Healthcare sector

High & Low

All-time High

$16.45 M
GCTK TTM cash flow from financing activities is currently -69.85% below its historical high of $16.45 million

3-Year Low

$0.00
GCTK TTM cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GCTK previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
GCTK next earnings announcement is scheduled for May 15, 2025

OtherGCTKcash flowmetrics:

TTM CFI

-$104.00 K
GCTK TTM cash flow from investing activities is -$104.00 thousand

TTM CFO

-$11.40 M
GCTK TTM cash flow from operations is -$11.40 million

TTM FCF

-$11.51 M
GCTK TTM free cash flow is -$11.51 million

TTM CAPEX

-
GCTK TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GCTK Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%+100.0%-43.2%
3 y3 years-32.9%--
5 y5 years+75.9%+100.0%-61.9%

GCTK Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-100.0%-49.8%-100.0%-43.2%-100.0%
5 y5-year-32.9%-100.0%-66.3%>+9999.0%-69.8%-100.0%
alltimeall time-32.9%+1994.1%-66.3%+1051.1%-69.8%+1176.2%

GlucoTrack Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.38 M(+655.2%)
$4.96 M(+755.2%)
Jun 2024
-
$580.00 K(>+9900.0%)
$580.00 K(-93.4%)
Dec 2023
$8.73 M(>+9900.0%)
$0.00(0.0%)
$8.73 M(0.0%)
Sep 2023
-
$0.00(-100.0%)
$8.73 M(0.0%)
Jun 2023
-
$8.73 M(>+9900.0%)
$8.73 M(>+9900.0%)
Dec 2022
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2022
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2020
$13.01 M(+209.9%)
$0.00(0.0%)
$13.01 M(+0.0%)
Sep 2020
-
$0.00(0.0%)
$13.01 M(0.0%)
Jun 2020
-
$0.00(-100.0%)
$13.01 M(-20.9%)
Mar 2020
-
$13.01 M(<-9900.0%)
$16.45 M(+291.9%)
Dec 2019
$4.20 M(-15.4%)
-$600.00(<-9900.0%)
$4.20 M(-5.8%)
Sep 2019
-
$0.00(-100.0%)
$4.45 M(-33.9%)
Jun 2019
-
$3.44 M(+355.3%)
$6.74 M(+67.7%)
Mar 2019
-
$756.10 K(+195.4%)
$4.02 M(-19.0%)
Dec 2018
$4.96 M(-13.7%)
$256.00 K(-88.8%)
$4.96 M(-2.4%)
Sep 2018
-
$2.29 M(+217.3%)
$5.08 M(+39.3%)
Jun 2018
-
$720.80 K(-57.5%)
$3.65 M(-24.8%)
Mar 2018
-
$1.70 M(+350.7%)
$4.85 M(-15.7%)
Dec 2017
$5.75 M(+16.5%)
$376.70 K(-55.9%)
$5.75 M(-1.0%)
Sep 2017
-
$853.80 K(-55.6%)
$5.81 M(+1.7%)
Jun 2017
-
$1.92 M(-26.1%)
$5.71 M(-23.9%)
Mar 2017
-
$2.60 M(+500.4%)
$7.51 M(+52.1%)
DateAnnualQuarterlyTTM
Dec 2016
$4.94 M(-1171.1%)
$432.90 K(-42.9%)
$4.94 M(+8.9%)
Sep 2016
-
$757.90 K(-79.6%)
$4.54 M(+20.2%)
Jun 2016
-
$3.72 M(>+9900.0%)
$3.77 M(>+9900.0%)
Mar 2016
-
$27.40 K(-12.7%)
$27.00 K(-105.9%)
Dec 2015
-$460.90 K(-106.6%)
$31.40 K(-692.5%)
-$460.90 K(-123.8%)
Sep 2015
-
-$5300.00(-80.0%)
$1.94 M(-70.9%)
Jun 2015
-
-$26.50 K(-94.2%)
$6.67 M(+1.4%)
Mar 2015
-
-$460.50 K(-118.9%)
$6.58 M(-5.6%)
Dec 2014
$6.97 M(+37.9%)
$2.43 M(-48.6%)
$6.97 M(+60.1%)
Sep 2014
-
$4.73 M(-4161.6%)
$4.36 M(-1050.2%)
Jun 2014
-
-$116.40 K(+68.9%)
-$458.50 K(+11.2%)
Mar 2014
-
-$68.90 K(-62.9%)
-$412.20 K(-108.2%)
Dec 2013
$5.06 M(+430.2%)
-$185.80 K(+112.6%)
$5.06 M(-17.7%)
Sep 2013
-
-$87.40 K(+24.7%)
$6.14 M(-2.2%)
Jun 2013
-
-$70.10 K(-101.3%)
$6.28 M(-1.1%)
Mar 2013
-
$5.40 M(+498.2%)
$6.35 M(+566.3%)
Dec 2012
$953.50 K(-60.0%)
$902.50 K(+1669.6%)
$953.50 K(+1758.7%)
Sep 2012
-
$51.00 K(>+9900.0%)
$51.30 K(-96.5%)
Jun 2012
-
$0.00(0.0%)
$1.47 M(-18.9%)
Mar 2012
-
$0.00(-100.0%)
$1.81 M(-24.1%)
Dec 2011
$2.38 M(-17.8%)
$300.00(-100.0%)
$2.38 M(+0.0%)
Sep 2011
-
$1.47 M(+328.3%)
$2.38 M(+160.1%)
Jun 2011
-
$342.40 K(-40.3%)
$915.80 K(+59.7%)
Mar 2011
-
$573.40 K
$573.40 K
Dec 2010
$2.90 M
-
-

FAQ

  • What is GlucoTrack annual cash flow from financing activities?
  • What is the all time high annual CFF for GlucoTrack?
  • What is GlucoTrack annual CFF year-on-year change?
  • What is GlucoTrack quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for GlucoTrack?
  • What is GlucoTrack quarterly CFF year-on-year change?
  • What is GlucoTrack TTM cash flow from financing activities?
  • What is the all time high TTM CFF for GlucoTrack?
  • What is GlucoTrack TTM CFF year-on-year change?

What is GlucoTrack annual cash flow from financing activities?

The current annual CFF of GCTK is $8.73 M

What is the all time high annual CFF for GlucoTrack?

GlucoTrack all-time high annual cash flow from financing activities is $13.01 M

What is GlucoTrack annual CFF year-on-year change?

Over the past year, GCTK annual cash flow from financing activities has changed by +$8.73 M (+100.00%)

What is GlucoTrack quarterly cash flow from financing activities?

The current quarterly CFF of GCTK is $4.38 M

What is the all time high quarterly CFF for GlucoTrack?

GlucoTrack all-time high quarterly cash flow from financing activities is $13.01 M

What is GlucoTrack quarterly CFF year-on-year change?

Over the past year, GCTK quarterly cash flow from financing activities has changed by +$4.38 M (+100.00%)

What is GlucoTrack TTM cash flow from financing activities?

The current TTM CFF of GCTK is $4.96 M

What is the all time high TTM CFF for GlucoTrack?

GlucoTrack all-time high TTM cash flow from financing activities is $16.45 M

What is GlucoTrack TTM CFF year-on-year change?

Over the past year, GCTK TTM cash flow from financing activities has changed by -$3.77 M (-43.18%)